Abstract
In inflammatory bowel diseases (IBD), risk of thrombosis and production of antibodies are increased. In autoimmune and inflammatory disorders, a role of anti-prothrombin (aPT) antibodies in developing thrombosis has been hypothesised. The aim of the study is to evaluate the prevalence of aPT antibodies in IBD patients, with and without thrombosis.
| Original language | English |
|---|---|
| Pages (from-to) | 1281-1286 |
| Number of pages | 6 |
| Journal | International Journal of Colorectal Disease |
| Volume | 28 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Thrombosis
Fingerprint
Dive into the research topics of 'Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver